TheEdgeResearch
Home / Stocks / HDVY

Health Discovery Corporation (HDVY)

OTC Healthcare Medical - Healthcare Information Services
$0.00 ▲ +0.00%
Market Cap
$41,171
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
-8.29
52-Wk Range
0.00001-0.0002
CEO
Alan K. Hauser
Country
US
Currency
USD

Health Discovery Corporation operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Atlanta, GA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $41,171. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of -75900.0%. Its beta of -8.29 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.05
Price / Sales
41.17
Price / Book
0.11
EV / EBITDA
0.89
Gross margin
100.0%
Operating margin
-174200.0%
Net margin
-75900.0%
Return on equity
Debt / equity
0.57
Current ratio
1.67
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2001-11-09
Headquarters
Atlanta, GA, US
About Health Discovery Corporation

Health Discovery Corporation (HDC) is a U.S.-based enterprise specializing in pattern recognition. The company utilizes sophisticated mathematical approaches to scrutinize data, primarily within the realm of molecular diagnostics, with the goal of identifying underlying patterns. Its portfolio of intellectual property encompasses Support Vector Machines (SVMs), a class of mathematical algorithms, alongside biomarkers – which are biological indicators or genetic markers signifying specific disease conditions – and its proprietary Fractal Genomic Modeling technology. HDC was founded in 2001 and maintains its principal operations in Atlanta, Georgia.

Comparable companies

Health Discovery Corporation is most often compared with the following Healthcare names:

ACBMARYXAXMPIBXGIGRWOMRXQEBRRGDXQSXHHFWMGR
More research on HDVY
HDVY technical analysis HDVY TheEdge Score Compare against peers
Open full interactive analysis & DCF →